It has been reported that heterozygous KMT2D+/− mice display an altered metabolic phenotype hallmarked by enhanced glucose tolerance, insulin sensitivity, and a higher serum bile acid level [12], as well as resistance to high-fat diet-induced hepatic steatosis [13]. The gene discussed is INS; the disease is fatty liver disease.